A classification system to improve surgical planning for vascular access: isn't that what we need? [0.03%]
一个可改善血管通路手术计划的分类系统：这不是我们需要的吗？
Michela Bozzetto,Simona Zerbi
Michela Bozzetto
A case of siblings with end-stage kidney disease and retinal degeneration suggestive of partial Alström syndrome [0.03%]
疑似部分阿爾斯隆綜合征终末期肾脏病和视网膜变性综合征家系病例报告
Kanna Shinkawa,Akira Ishii,Taikou Kimura et al.
Kanna Shinkawa et al.
Introduction: Renal ciliopathy is a genetic disorder caused by abnormalities in primary cilia. Alström syndrome (AS) is a rare renal ciliopathy caused by mutations in the ALMS1 gene. The diagnostic criteria for AS includ...
Case Reports
Nephron. 2025 Jul 28:1-17. DOI:10.1159/000547625 2025
Joseph A Vassalotti,Anna Francis,Augusto Cesar Soares Dos Santos Jr et al.
Joseph A Vassalotti et al.
A Feasibility Cluster Randomised Control Trial of a Person-centred Fluid Adherence Intervention For Adults Receiving Haemodialysis [0.03%]
一项针对接受血液透析成人以患者为中心的液体依従性干预措施功效集群随机对照试验
Hemamali Jagodage,Ann Bonner,Amanda McGuire et al.
Hemamali Jagodage et al.
Introduction: Adherence to fluid restriction is an essential component of haemodialysis (HD) self-management, although educational interventions are rarely adjusted to meet a person's health literacy abilities. This study...
Stanislav Kmoch,Martina Živná,Moran Dvela-Levitt et al.
Stanislav Kmoch et al.
David G Warnock,Aleš Linhart,Anthony J Bleyer et al.
David G Warnock et al.
Editorial
Nephron. 2025 Jun 30:1-5. DOI:10.1159/000546085 2025
Acute Antibody-Mediated Rejection Associated with Anti-MICA Antibodies in Long-Term Kidney Transplant: A Case Study [0.03%]
针对抗MICA抗体的急性抗体介导排斥反应一例长期存活肾移植患者的病例报道
Hiroaki Yonishi,Tomoko Namba-Hamano,Shigeaki Nakazawa et al.
Hiroaki Yonishi et al.
Introduction: Advances in immunosuppressive therapy have improved kidney transplant outcomes; however, antibody-mediated rejection (ABMR) still affects graft survival. Herein, we present a case of a 46-year-old woman who ...
Case Reports
Nephron. 2025 Jun 24:1-12. DOI:10.1159/000546963 2025
Maturation of lysosomal α-galactosidase A and implications for Fabry Disease [0.03%]
α-半乳糖苷酶A的溶酶体成熟及其对法布雷病的意义
Efecan Aral,Scott C Garman
Efecan Aral
Background: Fabry disease is an inherited metabolic disease that is caused by an abnormal accumulation of sphingolipids, including globotriaosylceramide (Gb3), in lysosomes. Patients with Fabry disease have insufficient l...
Review
Nephron. 2025 Jun 17:1-11. DOI:10.1159/000546916 2025
Thrombotic Microangiopathy in Renal Allograft Induced by Valproic Acid Treatment in addition to Tacrolimus and Everolimus: A Case Report [0.03%]
加巴喷平诱导的肾移植后的血栓性微血管病：他克莫司和依维莫司治疗基础上的个案报告
Azusa Kobayashi,Asami Takeda,Shoji Saito et al.
Azusa Kobayashi et al.
Thrombotic microangiopathy (TMA) is a known complication in renal transplant recipients and is often associated with drugs like calcineurin inhibitors (CNI) and mammalian target of rapamycin (mTOR) inhibitors. Additionally, toxic levels of ...
Case Reports
Nephron. 2025 Jun 12:1-11. DOI:10.1159/000546925 2025
Comparing RCRI and AUB-HAS2 in ESRD Patients Undergoing Non-Cardiac Surgery, a retrospective Analysis of the National Surgical Quality Improvement Program database [0.03%]
一项回顾性分析：对比RCRI和AUB-HAS2在终末期肾病患者中进行非心脏手术的有效性——全国外科质量改进计划数据库分析
Ritesh Patel,Katherine DiPastina,Vipul Bhat et al.
Ritesh Patel et al.
Background: End-stage renal disease (ESRD) patients are at a higher risk of perioperative complications. Existing perioperative risk assessment tools have been mainly validated in the general population. Despite the heigh...